Casdin Capital Investments

Casdin Capital has invested in 202 companies and its latest investment was Leyden Labs on Jan 08, 2025

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Leyden Labs is a Netherlands-based pharmaceutical company that develops and commercializes medicines for the treatment of infectious diseases.
$70M
Jan 08, 2025
-
Auron is a Massachusetts-based biotechnology company that develops and commercializes therapies for the treatment of cancer.
$27M
Dec 17, 2024
-
Maze is a California-based biopharmaceutical company that develops and commercializes medicines for the treatment of genetic diseases.
$115M
Dec 02, 2024
-
Neurogene is a pharmaceutical company that develops and commercializes genetic medicines for the treatment of neurological diseases.
$200M
Nov 03, 2024
-
Genome Medical is a California-based digital health company that offers virtual genetic care services for patients.
$75.3M
Sep 09, 2024
-

Frequently Asked Questions about Casdin Capital

  1. What is Casdin Capital investing in?

    Casdin Capital has invested in 202 companies including Leyden Labs, Auron and Maze
  2. What company did Casdin Capital invest in?

    Casdin Capital invested in a total 202 companies including Leyden Labs, Auron and Maze
  1. What are the top 5 investments by Casdin Capital?

    The top companies in which Casdin Capital invested are Leyden Labs, Auron, Maze, Neurogene and Genome Medical